Viramal
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
106 New Bond St, London, Greater London,...Phone Number
+44 2074953052Website
www.viramal.comRevenue
<$5 MillionIndustry
About Viramal
Viramal Org Chart
Is Viramal your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Viramal has new funding data
Check out if Viramal is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Viramal
Product Launch: Get notified when Viramal launches new products
Click to see if Viramal had a recent Job posting/layoffs
Check if Viramal has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Viramal recently announced quarterly report
Viramal, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Viramal
Find 3 more new buyers
Compare Similar Companies to Viramal
Compare insights from companies similar to Viramal, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Viramal is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Viramal is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Viramal.
Viramal Tech Stack
A closer look at the technologies used by Viramal
Viramal News & Media
Acerus Reports Second Quarter 2018 Financial Results
TORONTO--(BUSINESS WIRE)--Acerus Pharmaceuticals Corporation (TSX: ASP) (“Acerus” or the “Company”) today reported its financial results for the three months and six months ended June 30, 2018. Unless otherwise noted, all amounts are in U.S. dollars. Second Quarter Operational and Financial Highlights Increased product revenue by 63% to $2.0 million versus $1.2 million in the same three-month period in the prior year; Received notice of approval of Natesto® in South Korea for the treatment of hAcerus Enters into a Licensing Agreement with Viramal to Commercialize the Elegant™ Franchise in Canada
TORONTO--(BUSINESS WIRE)--Acerus Pharmaceuticals Corporation (TSX:ASP) (“Acerus” or the “Company”) today announced that it has entered into a license, development and supply agreement with Viramal Limited (“Viramal”), a London-based specialty pharmaceutical company developing therapeutics that improve the quality of women’s health, granting Acerus the exclusive rights to commercialize the Elegant™ franchise in Canada. The Elegant™ franchise comprises Elegant™ Vaginal Moisturizer, which provides
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Viramal
Viramal is a UK-based pharmaceutical company specializing in transformative healthcare products for women, with a focus on addressing unmet medical needs in women's sexual and reproductive health. The company offers innovative therapies for various conditions such as endometriosis, chronic pelvic pain, and menopause, utilizing non-invasive delivery... Read More